Atacana Group > Resources Center > Case Studies > Exploration for Portfolio Expansion and Product Acquisition
Dark Mode

Exploration for Portfolio Expansion and Product Acquisition

Exploration for Portfolio Expansion and Product Acquisition
Atacana Group


Identify the next blockbuster opportunity for our partner – both in MoA and potential indications


  • Our partner has a blockbuster drug reaching its loss of exclusivity in the near-future
  • To protect their overall portfolio, our partner was considering entry into a “hot” new MoA with the potential to expand into multiple indications

Key Question:

What new MoA provides the highest future value (E.g., highest efficacy, best safety, broadest therapeutic application)?


  • Landscape understanding: Secondary research to create in-depth landscapes of the indications of interest
  • MoA identification: Identify MoAs with promising potential (meeting unmet needs, new RoA, etc.)
  • Opportunity Ranking: Identify therapeutic areas of “low-hanging fruit” with immediate benefits and longer-term areas of wins


Acquisition: Following our assessment, our partner acquired an asset in the next “hot” MoA class with potential for expansion in multiple therapeutic areas

Investment: Our partner has begun significant investment in their new asset. They have already formalized plans to initiate Phase 3 studies in the “low hanging fruit” markets to launch their best-in-class asset


“The deep-dive into the landscape and assets was very helpful and really reconfirmed our initial analysis into this MoA”

– New Asset Lead